Antitrust

OpenAI urged the attorneys general of California and Delaware to investigate Elon Musk and associates for alleged "improper and anti-competitive behavior," claiming his ongoing lawsuit—seeking over $100 billion in damages—could cripple its nonprofit foundation and hinder efforts to develop artificial general intelligence (AGI) for humanity's benefit.[1][2][3][4]

Apple's App Store saw 235,800 new apps submitted in Q1 2026, an 84% increase from Q1 2025, reversing a 48% decline from 2016-2024, driven by vibe coding—AI tools like Cursor, Claude Code, and Anthropic's offerings that generate code from natural language prompts.[1][5][6] This follows 557,000-600,000 new apps in 2025, with Sensor Tower noting 56% monthly submission growth by Dec 2025 and 54.8% in Jan 2026.[1][2][3][5] Vibe coding, coined by OpenAI cofounder Andrej Karpathy in Feb 2025, enables rapid app creation even by novices, flooding submissions and straining review processes, with times rising from 24 hours to 30 days.[1][3][6]

Core Event: Anthropic announced Claude Mythos, its most powerful AI model to date, alongside Project Glasswing, an initiative granting early access to over 40 major technology companies to identify and patch vulnerabilities in their systems before the model's broader release.[1][6] The announcement came approximately two weeks after Anthropic accidentally leaked internal documents describing the model due to a misconfigured content management system.[4][6]

Neurocrine Biosciences announced on April 6, 2026, a definitive agreement to acquire Soleno Therapeutics for $2.9 billion in cash at $53 per share, a 34% premium to Soleno's April 2 closing price and 51% above its 30-day average. The deal, approved by both boards and expected to close within 90 days pending antitrust review and other conditions, will be funded by Neurocrine's $1.48 billion in cash equivalents (as of December 31, 2025) plus modest pre-payable debt.[1][2][3][5][6][9]